Yesintek®
INDICATIONS AND USAGE
YESINTEK is a human interleukin-12 and -23 antagonist indicated for the treatment of:
Adult patients with:
-
moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy. (1.1)
-
active psoriatic arthritis (PsA). (1.2)
-
moderately to severely active Crohn’s disease (CD). (1.3)
-
moderately to severely active ulcerative colitis. (1.4)
Referral Form: |
MANUFACTURER: Sandoz Inc. |
CLASS: Monoclonal Antibody (mAb)
Interleukin Inhibitor - Specifically: IL-12 and IL-23 antagonist |
|
PRESCRIBED BY:
|
|
HOW ADMINISTERED: Subcutaneous Injection |
|
FREQUENCY: Initially once every 2 weeks for the first 3 doses. Then, once injection every 4 weeks.
|
Length of infusion: About 30 mins |
FOR MORE INFORMATION: |
Related drugs
